Module 1:Introduction: Dr Shubhi from Medical Learning Hub welcomed all the participants, speakers and panelists explaining the flow of event. First poll was raised for the online and onsite participants.
Module 2:Message from Cepheid leadership team: Mrs Megha Buravalli, Regional Sales Manager, Cepheid India Pvt Ltd enlightened the participants regarding Akshay Bharat, she believed that DR TB should be made aware and cepheid believes to be a strong partner to deliver care to the patients.

Module 3: Message from Karnataka Pulmonary Association: Dr Shivalingaswamy Salimath, Welcomed all the participants for Akshay Bharat, on behalf of KPA and aimed towards TB Mukt Bharat

Module 4: Message from Chief guest: Dr Anil S, State TB officer, Karnataka, enlightned all the audience about the picture of TB in the state of Karnataka. He discussed about the role of state towards treatment and management of TB.

Module 5: Message from Chief guest: Dr Nirmala, Associate Director, NTEP, Karnataka shared her insights towards the aim of the CME. She discussed about new guidelines for treatment and management of NTEP.

Module 6: Tuberculosis burden: Global & Indian scenario: Dr.Rehana Begum ,Project Lead KHPT (Karnataka Health Promotion Trust), Bengaluru discussed about the global burden of TB. Kewy points of discussion were:

• TB burden
• India's comitment
• Ellimination of TB
• National TB prevalence survey

Module 7: Clinical Diagnosis of  Tuberculosis: Lt. Col. Dr. S Narayanan,    Consultant Pulmonologist, Command Hospital, Bengaluru, discussed about clinical diagnosis of Tuberculosis. Key points of discussion were:

• Risk Factors
• Pulmonary Tuberculosis
• Lymph node Tuberculosis- Thoracic and Extrathoracic
• Tuberculous Pleurisy
• Bone & Joint Tuberculosis
• Genito urinary Tuberculosis
• Abdominal Tuberculosis
• CNS Tuberculosis
• Cutaneous Tuberculosis

Module 8: New Advancements in molecular TB diagnostics: Dr.Sneha S Hegadi, Consultant Microbiologist, Neuberg Anand Reference Laboratory, Bengaluru discussed about the following:

• Status of drug resistant TB
• Causes of drug resistance
• Diagnostic modalities of TB
• Past, present and future of diagnostic modalities
• Culture
• XPERT MTB/RIF ULTRA
• Xpert MTB/XDR Assay
• Truenat MTB, MTB Plus and MTB-RIF Dx assays and many more

Module 9: Radiology of Tuberculosis: Dr. Chandan Giriyappa, Professor Radiology, SS Institute of Medical Sciences, Karnataka spoke about the radiology and Tubrculosis. Key points of discussion were:

• Primary TB diagnosis
• Airspace consolidation
• Extensive lung deconstruction
• Pneumothorax
• Radiological views

Module 10: Management of Drug-Sensitive (DS) TB : Dr.Ravi Kumar, Professor and Head- Respiratory Medicine, SMCRI-Tumakuru, discussed about Management of Drug Sensitive TB. Key points of discussion were:

• Goal and objectives of treatment
• Scientific basis of treatment
• Case definitions
• Fixed Dose Combinations (FDC)
• Treatment Regimen and drug dosages
• Operational guidelines for treatment initiation
• Treatment support systems
• Follow-up of treatment
• Contacts
• IPT
• Flow of patients
• Treatment outcomes
• Prevention and management of Adverse reactions to drugs
• Management of Special situations and comorbid conditions

Module 11: Management of Drug-Resistant (DR) TB: Dr Somasekhar N, Director National Tuberculosis Institute(NTI), Bengaluru, enlightened the audience about management of drug resistant TB, Key Points from discussion were:

• Estimated number of TB
• Global TB report
• Causes of DR TB
• DR TB diagnosis
• DR TB management
• Management algorithm

Module 12: New Horizon in drug resistance TB diagnosis: Dr Bornali Datta discussed about the new innovations for diagnosis and management of DR TB. Key points of discussion were

• Point of Care Diagnosis
• Utility in Current TB Testing Algorithm- India
• Diagnostics for One of the Oldest Scourges of Humankind
• Need of Ultra
• Xpert® MTB/XDR* Resistance Detection
• Prototype Xpert® MTB/XDR*
• Use of Xpert ® MTB/XDR test and 10-color instruments
• Patient Pathway for Drug Resistance TB in India

Module 13: Panel Discussion:   Clinical and Laboratory Management of tuberculosis Infection in India , further panel discussion was carried out with eminent panelists like Dr.Huliraju N,Dr.Ranjeetha Adhikary,Dr.K S Satish, Dr.Mamatha H G, Dr.Somasekhar N, Dr.Ranganath R, Dr.Ravindra Mehta,Dr.H V Suryanarayana,Dr Gayathri and Dr Pawan.  It was moderated by Dr Satyanarayana Mysore, Some of the questions were:

• What’s your view on technologies such as 10-color technology which was just explained, do you think this will make a difference in multiplexing more targets and help in diagnosing complex diseases going forward?Overall management of DRTB patients, and their mitigation
• Once the patient is diagnosed as positive for MTB on CBNAAT, what is the ideal course of action to be adopted towards better patient management ?
• How test and treat model on the same day(in 3 hours) can help combat complicated TB infections?
• What is your view on decentralizing the DRTB management?
• What do you think about the concept of reflex testing and ruling out the possibility of INH-mono resistance (It's a growing concern in the region)?
• What are the new drug classes for drug-resistant TB and pls tell us about how to formulate the DR TB regime and when do we choose to give it?

Module 14: Vote of Thanks: Mr Varun Suneja, Commercial Marketing Manager, APAC for Cepheid delivered vote of thanks, thanking all the participating organizations, attendees, speakers and panellist.

We wish you a great learning experience!